LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 2533

Search options

  1. Article: Role of H

    Mohiuddin Chowdhury, Abu Taiub Mohammed / Kamal, Aktar / Abbas, Md Kafil Uddin / Karim, Md Rezaul / Ali, Md Ahsan / Talukder, Shubhashis / Hamidullah Mehedi, H M / Hassan, Hamid / Shahin, Abul Hossain / Li, Yarui / He, Shuixiang

    World journal of clinical cases

    2022  Volume 10, Issue 23, Page(s) 8170–8185

    Abstract: ... as options for the medical management of COVID-19 patients.: Aim: To evaluate the role of the H: Methods ... mg to 60 mg oral formulation every 8 h with other treatment as given), and control group "B ... for 24 h; time to symptomatic recovery, defined as the duration in days (from randomization) required ...

    Abstract Background: Coronavirus disease 2019 (COVID-19) is a global pandemic putting the population at a high risk of infection-related health hazards, mortality and a potential failure of proper medical therapies. Therefore, it is necessary to evaluate the potential use of the existing drugs that could be used as options for the medical management of COVID-19 patients.
    Aim: To evaluate the role of the H
    Methods: This study was done on seriously ill COVID-19 patients admitted to the intensive care unit (ICU) from different institutes in Bangladesh. Patients were divided into famotidine treatment group "A" (famotidine 40 mg to 60 mg oral formulation every 8 h with other treatment as given), and control group "B" (treatment as given). National early warning score (NEWS)-2, and sequential organ failure assessment day-1 score was calculated to evaluate the outcome. Outcomes were evaluated by the time required for clinical improvement, characterized as duration required from enrollment to the achievement of NEWS-2 of ≤ 2 maintained for 24 h; time to symptomatic recovery, defined as the duration in days (from randomization) required for the recovery of the COVID-19 symptoms; mortality rate; duration of ICU and hospital stay; total period of hospitalization; the rate of supplementary oxygen requirement; the computed tomography (CT) chest recovery (%), the time required for the viral clearance and "NEWS-2" on discharge.
    Results: A total of 208 patients were enrolled in this study with 104 patients in each group. The famotidine treatment group had comparatively better recovery of 75% and a low mortality of 25% than the control with a recovery of 70% and a mortality of 30%. Duration of clinical improvement (group A 9.53 d, group B 14.21 d); hospitalization period among the recovered patients (group A 13.04 d, group B 16.31 d), pulmonary improvement in chest CT (group A 21.7%, group B 13.2%), and the time for viral clearance (group A 20.7 d, group B 23.8 d) were found to be statistically significant
    Conclusion: According to our study, treatment with famotidine achieved a better clinical outcome compared to the control group in severe COVID-19 illness, although no significant survival benefit was found.
    Language English
    Publishing date 2022-02-14
    Publishing country United States
    Document type Clinical Trial
    ISSN 2307-8960
    ISSN 2307-8960
    DOI 10.12998/wjcc.v10.i23.8170
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article: Recent Advances in Electrochemical Sensing of Hydrogen Peroxide (H

    Ahmad, Touqeer / Iqbal, Ayesha / Halim, Sobia Ahsan / Uddin, Jalal / Khan, Ajmal / El Deeb, Sami / Al-Harrasi, Ahmed

    Nanomaterials (Basel, Switzerland)

    2022  Volume 12, Issue 9

    Abstract: ... encouraging results. Cancerous cells are well known for their substantial amounts of hydrogen peroxide (H ...

    Abstract Cancer is by far the most common cause of death worldwide. There are more than 200 types of cancer known hitherto depending upon the origin and type. Early diagnosis of cancer provides better disease prognosis and the best chance for a cure. This fact prompts world-leading scientists and clinicians to develop techniques for the early detection of cancer. Thus, less morbidity and lower mortality rates are envisioned. The latest advancements in the diagnosis of cancer utilizing nanotechnology have manifested encouraging results. Cancerous cells are well known for their substantial amounts of hydrogen peroxide (H
    Language English
    Publishing date 2022-04-26
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662255-5
    ISSN 2079-4991
    ISSN 2079-4991
    DOI 10.3390/nano12091475
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Optimisation and Stability of Rh Particles on Noble Metal Films Immobilised on H

    Ahsan, Mohebul / Hossain, Md Mosaraf / Almahri, Albandary / Rahman, Mohammed M / Hasnat, Mohammad A

    Chemistry, an Asian journal

    2022  Volume 17, Issue 9, Page(s) e202200150

    Abstract: ... immobilized on Pt and Pd films deposited on H ...

    Abstract During the electrocatalytic reduction of nitrate, nitrite is often evolved as a product along with ammonia due to the sluggish nitrite-to-ammonia conversion process compared to the nitrate-to-nitrite conversion step. Rhodium metal has been proven to enhance nitrite-to-ammonia conversion rates, yielding ammonia as the only final product. In the present article, we have shown how effectively Rh nanoparticles immobilized on Pt and Pd films deposited on H
    Language English
    Publishing date 2022-04-01
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2233006-9
    ISSN 1861-471X ; 1861-4728
    ISSN (online) 1861-471X
    ISSN 1861-4728
    DOI 10.1002/asia.202200150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Deep learning-assisted co-registration of full-spectral autofluorescence lifetime microscopic images with H&E-stained histology images.

    Wang, Qiang / Fernandes, Susan / Williams, Gareth O S / Finlayson, Neil / Akram, Ahsan R / Dhaliwal, Kevin / Hopgood, James R / Vallejo, Marta

    Communications biology

    2022  Volume 5, Issue 1, Page(s) 1119

    Abstract: Autofluorescence lifetime images reveal unique characteristics of endogenous fluorescence in biological samples. Comprehensive understanding and clinical diagnosis rely on co-registration with the gold standard, histology images, which is extremely ... ...

    Abstract Autofluorescence lifetime images reveal unique characteristics of endogenous fluorescence in biological samples. Comprehensive understanding and clinical diagnosis rely on co-registration with the gold standard, histology images, which is extremely challenging due to the difference of both images. Here, we show an unsupervised image-to-image translation network that significantly improves the success of the co-registration using a conventional optimisation-based regression network, applicable to autofluorescence lifetime images at different emission wavelengths. A preliminary blind comparison by experienced researchers shows the superiority of our method on co-registration. The results also indicate that the approach is applicable to various image formats, like fluorescence in-tensity images. With the registration, stitching outcomes illustrate the distinct differences of the spectral lifetime across an unstained tissue, enabling macro-level rapid visual identification of lung cancer and cellular-level characterisation of cell variants and common types. The approach could be effortlessly extended to lifetime images beyond this range and other staining technologies.
    MeSH term(s) Deep Learning ; Staining and Labeling
    Language English
    Publishing date 2022-10-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-022-04090-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article ; Online: Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)- N -aryl-4 H -1,2,4-triazol-3-amine Analogs

    Mohamed Jawed Ahsan / Krishna Gautam / Amena Ali / Abuzer Ali / Abdulmalik Saleh Alfawaz Altamimi / Salahuddin / Manal A. Alossaimi / S. V. V. N. S. M. Lakshmi / Md. Faiyaz Ahsan

    Molecules, Vol 28, Iss 6936, p

    2023  Volume 6936

    Abstract: In the current study, we described the synthesis of ten new 5-(3-Bromophenyl)- N -aryl-4 H -1,2,4 ... electrostatic interactions observed: H-bond and halogen bond. Ligand 4i had a binding affinity of −8.149 kcal ... mol with the tubulin–combretastatin A-4 binding site and displayed a H-bond interaction ...

    Abstract In the current study, we described the synthesis of ten new 5-(3-Bromophenyl)- N -aryl-4 H -1,2,4-triazol-3-amine analogs ( 4a–j ), as well as their characterization, anticancer activity, molecular docking studies, ADME, and toxicity prediction. The title compounds ( 4a–j ) were prepared in three steps, starting from substituted anilines in a satisfactory yield, followed by their characterization via spectroscopic techniques. The National Cancer Institute (NCI US) protocol was followed to test the compounds’ ( 4a–j ) anticancer activity against nine panels of 58 cancer cell lines at a concentration of 10 −5 M, and growth percent (GP) as well as percent growth inhibition (PGI) were calculated. Some of the compounds demonstrated significant anticancer activity against a few cancer cell lines. The CNS cancer cell line SNB-75, which showed a PGI of 41.25 percent, was discovered to be the most sensitive cancer cell line to the tested compound 4e . The mean GP of compound 4i was found to be the most promising among the series of compounds. The five cancer cell lines that were found to be the most susceptible to compound 4i were SNB-75, UO-31, CCRF-CEM, EKVX, and OVCAR-5; these five cell lines showed PGIs of 38.94, 30.14, 26.92, 26.61, and 23.12 percent, respectively, at 10 −5 M. The inhibition of tubulin is one of the primary molecular targets of many anticancer agents; hence, the compounds ( 4a–j ) were further subjected to molecular docking studies looking at the tubulin–combretastatin A-4 binding site (PDB ID: 5LYJ) of tubulin. The binding affinities were found to be efficient, ranging from −6.502 to −8.341 kcal/mol, with two major electrostatic interactions observed: H-bond and halogen bond. Ligand 4i had a binding affinity of −8.149 kcal/mol with the tubulin–combretastatin A-4 binding site and displayed a H-bond interaction with the residue Asn258. The ADME and toxicity prediction studies for each compound were carried out using SwissADME and ProTox-II software. None of the compounds’ ADME predictions showed that ...
    Keywords anticancer ; ADME studies ; cell lines ; molecular docking ; triazole ; tubulin ; Organic chemistry ; QD241-441
    Subject code 540 ; 500
    Language English
    Publishing date 2023-10-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article ; Online: Recent Advances in Electrochemical Sensing of Hydrogen Peroxide (H 2 O 2 ) Released from Cancer Cells

    Touqeer Ahmad / Ayesha Iqbal / Sobia Ahsan Halim / Jalal Uddin / Ajmal Khan / Sami El Deeb / Ahmed Al-Harrasi

    Nanomaterials, Vol 12, Iss 1475, p

    2022  Volume 1475

    Abstract: ... encouraging results. Cancerous cells are well known for their substantial amounts of hydrogen peroxide (H 2 O ... 2 ). The common methods for the detection of H 2 O 2 include colorimetry, titration, chromatography ... The production of detectable amounts of H 2 O 2 by cancerous cells has promoted the use of bio- and ...

    Abstract Cancer is by far the most common cause of death worldwide. There are more than 200 types of cancer known hitherto depending upon the origin and type. Early diagnosis of cancer provides better disease prognosis and the best chance for a cure. This fact prompts world-leading scientists and clinicians to develop techniques for the early detection of cancer. Thus, less morbidity and lower mortality rates are envisioned. The latest advancements in the diagnosis of cancer utilizing nanotechnology have manifested encouraging results. Cancerous cells are well known for their substantial amounts of hydrogen peroxide (H 2 O 2 ). The common methods for the detection of H 2 O 2 include colorimetry, titration, chromatography, spectrophotometry, fluorimetry, and chemiluminescence. These methods commonly lack selectivity, sensitivity, and reproducibility and have prolonged analytical time. New biosensors are reported to circumvent these obstacles. The production of detectable amounts of H 2 O 2 by cancerous cells has promoted the use of bio- and electrochemical sensors because of their high sensitivity, selectivity, robustness, and miniaturized point-of-care cancer diagnostics. Thus, this review will emphasize the principles, analytical parameters, advantages, and disadvantages of the latest electrochemical biosensors in the detection of H 2 O 2 . It will provide a summary of the latest technological advancements of biosensors based on potentiometric, impedimetric, amperometric, and voltammetric H 2 O 2 detection. Moreover, it will critically describe the classification of biosensors based on the material, nature, conjugation, and carbon-nanocomposite electrodes for rapid and effective detection of H 2 O 2 , which can be useful in the early detection of cancerous cells.
    Keywords analytical methods ; biosensors ; carbon materials ; electrochemical sensing ; H 2 O 2 ; nanomaterial ; Chemistry ; QD1-999
    Subject code 290
    Language English
    Publishing date 2022-04-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  7. Article ; Online: Revision of the high-altitude genus Hyphinomos Uvarov, 1921 (Orthoptera: Tettigoniidae) with a redescription and new data on mating behavior and acoustic signals of H. svenhedini Ramme, 1950.

    Ali, Ahsan / Jaiswara, Ranjana / Monaal / Kumar, Neelima R / Bharti, Umesh / Heller, Klaus-Gerhard

    Zootaxa

    2022  Volume 5099, Issue 3, Page(s) 301–324

    Abstract: ... in mountain ranges of the Himalayas. In this paper, we amend the description of H. svenhedini by adding new data ...

    Abstract High mountains are known for their unique habitats and extreme climatic conditions. Many inhabitants of this area are specialists and are known as hypsobionts. Among Ensifera, only selected species from different genera are true hypsobionts. Species in the genus Hyphinomos are one of them. Hyphinomos occurs only between 3800 and 5500 m a.s.l., and is known from two species, fasciata Uvarov, 1921 and svenhedini Ramme, 1950. Until recently they were both known only from their type localities situated in mountain ranges of the Himalayas. In this paper, we amend the description of H. svenhedini by adding new data on its distribution, habitat, structure of the male genitalia, stridulatory structures, acoustic signals (long-distance and courtship), and mating behavior. In addition, we have revised the description of Hyphinomos.
    MeSH term(s) Acoustics ; Altitude ; Animal Distribution ; Animals ; Ecosystem ; Male ; Orthoptera
    Language English
    Publishing date 2022-02-14
    Publishing country New Zealand
    Document type Journal Article
    ISSN 1175-5334
    ISSN (online) 1175-5334
    DOI 10.11646/zootaxa.5099.3.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  8. Article ; Online: Identification of the H&S (Health and Safety Factors) Involved in Infrastructure Projects in Developing Countries-A Sequential Mixed Method Approach of OLMT-Project.

    Nawaz, Ahsan / Su, Xing / Din, Qaiser Mohi Ud / Khalid, Muhammad Irslan / Bilal, Muhammad / Shah, Syyed Adnan Raheel

    International journal of environmental research and public health

    2020  Volume 17, Issue 2

    Abstract: ... OLMT)) to explore and identify the H&S (Health and Safety) factors that affect the local residents and ...

    Abstract Urbanization is playing a key role in big cities of developing countries, which, in effect, is increasing the population. This study takes care of the mega infrastructure project (Orange Line Metro Train (OLMT)) to explore and identify the H&S (Health and Safety) factors that affect the local residents and the main key stakeholders working on the project. A Sequential Mixed-Method approach of the OLMT-project includes qualitative and quantitative methods were adopted. The data have been collected from the targeted population working on the OLMT-project through a questionnaire. The main key finding of the study indicates that poor planning and a lack of communication between the public and government led to frustration. The most significant factors that identified in the study were unsafe to work practice, project scope constraints, lack in technical and material support, unsafe/bad condition, health/environment degradation, declination and loss of resources and time, no proper emergency system, and negligence in adopting safety rules and laws. The study also revealed that the consensus should also be noticed between the key stakeholders (e.g., contractors, clients, safety officials, academia) in the second round of the Delphi survey of the project. The study findings will help the key stakeholders to prioritize their energies towards attaining zero levels of inadequate health and safety practices in infrastructure projects. The study outcomes can also be generalized for the other developing countries having a similar work scenario.
    MeSH term(s) Cities ; Construction Industry ; Developing Countries ; Health Services/statistics & numerical data ; Humans ; Occupational Health/statistics & numerical data ; Pakistan ; Urbanization
    Language English
    Publishing date 2020-01-19
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2175195-X
    ISSN 1660-4601 ; 1661-7827
    ISSN (online) 1660-4601
    ISSN 1661-7827
    DOI 10.3390/ijerph17020635
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells.

    Petrillo, Carolina / Thorne, Lucy G / Unali, Giulia / Schiroli, Giulia / Giordano, Anna M S / Piras, Francesco / Cuccovillo, Ivan / Petit, Sarah J / Ahsan, Fatima / Noursadeghi, Mahdad / Clare, Simon / Genovese, Pietro / Gentner, Bernhard / Naldini, Luigi / Towers, Greg J / Kajaste-Rudnitski, Anna

    Cell stem cell

    2018  Volume 23, Issue 6, Page(s) 820–832.e9

    Abstract: ... by cyclosporine H (CsH). CsH potently enhances gene transfer and editing in human long-term repopulating HSCs ...

    Abstract Innate immune factors may restrict hematopoietic stem cell (HSC) genetic engineering and contribute to broad individual variability in gene therapy outcomes. Here, we show that HSCs harbor an early, constitutively active innate immune block to lentiviral transduction that can be efficiently overcome by cyclosporine H (CsH). CsH potently enhances gene transfer and editing in human long-term repopulating HSCs by inhibiting interferon-induced transmembrane protein 3 (IFITM3), which potently restricts VSV glycoprotein-mediated vector entry. Importantly, individual variability in endogenous IFITM3 levels correlated with permissiveness of HSCs to lentiviral transduction, suggesting that CsH treatment will be useful for improving ex vivo gene therapy and standardizing HSC transduction across patients. Overall, our work unravels the involvement of innate pathogen recognition molecules in immune blocks to gene correction in primary human HSCs and highlights how these roadblocks can be overcome to develop innovative cell and gene therapies.
    MeSH term(s) Animals ; Cell Line ; Cyclosporine/pharmacology ; Female ; Gene Editing ; HEK293 Cells ; Hematopoietic Stem Cells/drug effects ; Hematopoietic Stem Cells/metabolism ; Humans ; Immunity, Innate/drug effects ; Lentivirus/drug effects ; Lentivirus/genetics ; Lentivirus/immunology ; Mice ; Mice, Inbred NOD ; Mice, Knockout ; Transduction, Genetic
    Chemical Substances Cyclosporine (83HN0GTJ6D) ; cyclosporin H (FUO6O3NDNH)
    Language English
    Publishing date 2018-11-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2375354-7
    ISSN 1875-9777 ; 1934-5909
    ISSN (online) 1875-9777
    ISSN 1934-5909
    DOI 10.1016/j.stem.2018.10.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6589: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.MG 75: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article: Search for neutral Higgs Bosons at high tanbeta in the b(h/H/A)-->btau;{+}tau;{-} channel.

    Abazov, V M / Abbott, B / Abolins, M / Acharya, B S / Adams, M / Adams, T / Aguilo, E / Ahsan, M / Alexeev, G D / Alkhazov, G / Alton, A / Alverson, G / Alves, G A / Anastasoaie, M / Ancu, L S / Andeen, T / Andrieu, B / Anzelc, M S / Aoki, M /
    Arnoud, Y / Arov, M / Arthaud, M / Askew, A / Asman, B / Assis Jesus, A C S / Atramentov, O / Avila, C / Badaud, F / Bagby, L / Baldin, B / Bandurin, D V / Banerjee, P / Banerjee, S / Barberis, E / Barfuss, A-F / Bargassa, P / Baringer, P / Barreto, J / Bartlett, J F / Bassler, U / Bauer, D / Beale, S / Bean, A / Begalli, M / Begel, M / Belanger-Champagne, C / Bellantoni, L / Bellavance, A / Benitez, J A / Beri, S B / Bernardi, G / Bernhard, R / Bertram, I / Besançon, M / Beuselinck, R / Bezzubov, V A / Bhat, P C / Bhatnagar, V / Blazey, G / Blekman, F / Blessing, S / Bloom, K / Boehnlein, A / Boline, D / Bolton, T A / Boos, E E / Borissov, G / Bose, T / Brandt, A / Brock, R / Brooijmans, G / Bross, A / Brown, D / Bu, X B / Buchanan, N J / Buchholz, D / Buehler, M / Buescher, V / Bunichev, V / Burdin, S / Burnett, T H / Buszello, C P / Calfayan, P / Calvet, S / Cammin, J / Carrasco-Lizarraga, M A / Carrera, E / Carvalho, W / Casey, B C K / Castilla-Valdez, H / Chakrabarti, S / Chakraborty, D / Chan, K M / Chandra, A / Cheu, E / Cho, D K / Choi, S / Choudhary, B / Christofek, L / Christoudias, T / Cihangir, S / Claes, D / Clutter, J / Cooke, M / Cooper, W E / Corcoran, M / Couderc, F / Cousinou, M-C / Crépé-Renaudin, S / Cuplov, V / Cutts, D / Cwiok, M / da Motta, H / Das, A / Davies, G / De, K / de Jong, S J / De La Cruz-Burelo, E / De Oliveira Martins, C / Devaughan, K / Déliot, F / Demarteau, M / Demina, R / Denisov, D / Denisov, S P / Desai, S / Diehl, H T / Diesburg, M / Dominguez, A / Dorland, T / Dubey, A / Dudko, L V / Duflot, L / Dugad, S R / Duggan, D / Duperrin, A / Dutt, S / Dyer, J / Dyshkant, A / Eads, M / Edmunds, D / Ellison, J / Elvira, V D / Enari, Y / Eno, S / Ermolov, P / Evans, H / Evdokimov, A / Evdokimov, V N / Ferapontov, A V / Ferbel, T / Fiedler, F / Filthaut, F / Fisher, W / Fisk, H E / Fortner, M / Fox, H / Fu, S / Fuess, S / Gadfort, T / Galea, C F / Garcia, C / Garcia-Bellido, A / Gavrilov, V / Gay, P / Geist, W / Geng, W / Gerber, C E / Gershtein, Y / Gillberg, D / Ginther, G / Gómez, B / Goussiou, A / Grannis, P D / Greenlee, H / Greenwood, Z D / Gregores, E M / Grenier, G / Gris, Ph / Grivaz, J-F / Grohsjean, A / Grünendahl, S / Grünewald, M W / Guo, F / Guo, J / Gutierrez, G / Gutierrez, P / Haas, A / Hadley, N J / Haefner, P / Hagopian, S / Haley, J / Hall, I / Hall, R E / Han, L / Harder, K / Harel, A / Hauptman, J M / Hays, J / Hebbeker, T / Hedin, D / Hegeman, J G / Heinson, A P / Heintz, U / Hensel, C / Herner, K / Hesketh, G / Hildreth, M D / Hirosky, R / Hoang, T / Hobbs, J D / Hoeneisen, B / Hohlfeld, M / Hossain, S / Houben, P / Hu, Y / Hubacek, Z / Hynek, V / Iashvili, I / Illingworth, R / Ito, A S / Jabeen, S / Jaffré, M / Jain, S / Jakobs, K / Jarvis, C / Jesik, R / Johns, K / Johnson, C / Johnson, M / Johnston, D / Jonckheere, A / Jonsson, P / Juste, A / Kajfasz, E / Karmanov, D / Kasper, P A / Katsanos, I / Kaushik, V / Kehoe, R / Kermiche, S / Khalatyan, N / Khanov, A / Kharchilava, A / Kharzheev, Y N / Khatidze, D / Kim, T J / Kirby, M H / Kirsch, M / Klima, B / Kohli, J M / Konrath, J-P / Kozelov, A V / Kraus, J / Kuhl, T / Kumar, A / Kupco, A / Kurca, T / Kuzmin, V A / Kvita, J / Lacroix, F / Lam, D / Lammers, S / Landsberg, G / Lebrun, P / Lee, W M / Leflat, A / Lellouch, J / Li, J / Li, L / Li, Q Z / Lietti, S M / Lim, J K / Lima, J G R / Lincoln, D / Linnemann, J / Lipaev, V V / Lipton, R / Liu, Y / Liu, Z / Lobodenko, A / Lokajicek, M / Love, P / Lubatti, H J / Luna-Garcia, R / Lyon, A L / Maciel, A K A / Mackin, D / Madaras, R J / Mättig, P / Magerkurth, A / Mal, P K / Malbouisson, H B / Malik, S / Malyshev, V L / Maravin, Y / Martin, B / McCarthy, R / Meijer, M M / Melnitchouk, A / Mendoza, L / Mercadante, P G / Merkin, M / Merritt, K W / Meyer, A / Meyer, J / Mitrevski, J / Mommsen, R K / Mondal, N K / Moore, R W / Moulik, T / Muanza, G S / Mulhearn, M / Mundal, O / Mundim, L / Nagy, E / Naimuddin, M / Narain, M / Neal, H A / Negret, J P / Neustroev, P / Nilsen, H / Nogima, H / Novaes, S F / Nunnemann, T / O'Neil, D C / Obrant, G / Ochando, C / Onoprienko, D / Oshima, N / Osman, N / Osta, J / Otec, R / Otero Y Garzón, G J / Owen, M / Padley, P / Pangilinan, M / Parashar, N / Park, S-J / Park, S K / Parsons, J / Partridge, R / Parua, N / Patwa, A / Pawloski, G / Penning, B / Perfilov, M / Peters, K / Peters, Y / Pétroff, P / Petteni, M / Piegaia, R / Piper, J / Pleier, M-A / Podesta-Lerma, P L M / Podstavkov, V M / Pogorelov, Y / Pol, M-E / Polozov, P / Pope, B G / Popov, A V / Potter, C / Prado da Silva, W L / Prosper, H B / Protopopescu, S / Qian, J / Quadt, A / Quinn, B / Rakitine, A / Rangel, M S / Ranjan, K / Ratoff, P N / Renkel, P / Rich, P / Rijssenbeek, M / Ripp-Baudot, I / Rizatdinova, F / Robinson, S / Rodrigues, R F / Rominsky, M / Royon, C / Rubinov, P / Ruchti, R / Safronov, G / Sajot, G / Sánchez-Hernández, A / Sanders, M P / Sanghi, B / Savage, G / Sawyer, L / Scanlon, T / Schaile, D / Schamberger, R D / Scheglov, Y / Schellman, H / Schliephake, T / Schlobohm, S / Schwanenberger, C / Schwartzman, A / Schwienhorst, R / Sekaric, J / Severini, H / Shabalina, E / Shamim, M / Shary, V / Shchukin, A A / Shivpuri, R K / Siccardi, V / Simak, V / Sirotenko, V / Skubic, P / Slattery, P / Smirnov, D / Snow, G R / Snow, J / Snyder, S / Söldner-Rembold, S / Sonnenschein, L / Sopczak, A / Sosebee, M / Soustruznik, K / Spurlock, B / Stark, J / Stolin, V / Stoyanova, D A / Strandberg, J / Strandberg, S / Strang, M A / Strauss, E / Strauss, M / Ströhmer, R / Strom, D / Stutte, L / Sumowidagdo, S / Svoisky, P / Sznajder, A / Tanasijczuk, A / Taylor, W / Tiller, B / Tissandier, F / Titov, M / Tokmenin, V V / Torchiani, I / Tsybychev, D / Tuchming, B / Tully, C / Tuts, P M / Unalan, R / Uvarov, L / Uvarov, S / Uzunyan, S / Vachon, B / van den Berg, P J / Van Kooten, R / van Leeuwen, W M / Varelas, N / Varnes, E W / Vasilyev, I A / Verdier, P / Vertogradov, L S / Verzocchi, M / Vilanova, D / Villeneuve-Seguier, F / Vint, P / Vokac, P / Voutilainen, M / Wagner, R / Wahl, H D / Wang, M H L S / Warchol, J / Watts, G / Wayne, M / Weber, G / Weber, M / Welty-Rieger, L / Wenger, A / Wermes, N / Wetstein, M / White, A / Wicke, D / Williams, M R J / Wilson, G W / Wimpenny, S J / Wobisch, M / Wood, D R / Wyatt, T R / Xie, Y / Xu, C / Yacoob, S / Yamada, R / Yang, W-C / Yasuda, T / Yatsunenko, Y A / Yin, H / Yip, K / Yoo, H D / Youn, S W / Yu, J / Zeitnitz, C / Zelitch, S / Zhao, T / Zhou, B / Zhu, J / Zielinski, M / Zieminska, D / Zieminski, A / Zivkovic, L / Zutshi, V / Zverev, E G

    Physical review letters

    2009  Volume 102, Issue 5, Page(s) 51804

    Abstract: The first search in pp[over ] collisions at sqrt[s]=1.96 TeV for the production of neutral Higgs bosons in association with bottom quarks and decaying in two tau leptons is presented. The cross section for this process is enhanced in many extensions of ... ...

    Abstract The first search in pp[over ] collisions at sqrt[s]=1.96 TeV for the production of neutral Higgs bosons in association with bottom quarks and decaying in two tau leptons is presented. The cross section for this process is enhanced in many extensions of the standard model, such as its minimal supersymmetric extension (MSSM) at large tanbeta. The data, corresponding to an integrated luminosity of 328 pb;{-1}, were collected with the D0 detector at the Fermilab Tevatron Collider. An upper limit is set on the production cross section of neutral Higgs bosons in the mass range of 90 to 150 GeV, and this limit is used to exclude part of the MSSM parameter space.
    Language English
    Publishing date 2009-02-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.102.051804
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Bonn / Germany

    Z 4' 58/153: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top